Replies to post #548857 on NorthWest Biotherapeutics Inc (NWBO)

[Atlas20]

What do you mean by, “they went with Moderna instead”? They reported encouraging findings of a trial that is still ongoing and will be ongoing for many more years. They don’t have to choose between one or the other even though I agree that dcvax is clearly superior…

[Doc logic]

hankmanhub,

Think about what Merck and NWBO know. L plus Poly ICLC equals greater than 50% long term (cure?) survival. Add a checkpoint inhibitor and what is the additive value? They have a pretty good idea by now and so does NWBO. NWBO is already up to bat with Moderna down the batting order significantly. L is ready, Direct in the wings. End game jockeying for position with big pharma having big media exposure and NWBO with results, manufacturing nearly ready and patients who will become aware whether or not big media outlets report or not because social media will clock them if they don’t move at the right time. Best wishes.

[X Master]

Merck will pay the $. Get ready.

[Horseb4CarT]

Given how the leading COVID vaccines seem to require tweaking for new variants and there’s talk of diminishing duration of effectiveness as each additional wave of boosters are deployed, and that for difficult hot cancers such as GBM, I feel better about the DCVax platform approach which inherently is “trained” on the individual’s particular tumor composition, and there hasn’t been any heart related side effects identified unlike the Covid type rna vaccines.